The female version of "Steve Jobs" fell down on biomedical care how to vote?

Last month, the American blood test company Theranos had a half-year scandal that knocked down the hammer, and the data was untrue. This former Silicon Valley unicorn was severely punished by the CMS shutting down the lab and canceling the license. This time shattered, both sounded a wake-up call in the highly innovative wave, it is also a prime example of biomedical investment risk direction. Is this area that is equipped with cutting-edge technology and strict market access conditions, and is it suitable for investment? And how to avoid the traps and risks in this process?

In order to understand the direction of biomedical and get first-hand investment advice, the reporter interviewed two investors in the biomedical field of TEEC Angel Fund, Dr. Jin Xuecheng and Dr. He Wei. TEEC Angel Fund is an angel fund of Tsinghua Entrepreneur Association TEEC, which is known for its focus on high-tech investment. In the 2016 Disriptor 50 list selected by the famous American media CNBC, the biotech company Ginkgo Bioworks they invested in ranked seventh. In the synthetic biology industry with great market potential, it is called the “leader” and “changer”.

The biomedical investment tipping point is within a few years

The development of the biomedical field has been relatively slow, and the payback period is generally more than ten years. Unlike social media or e-commerce startup projects, the development of biomedical entrepreneurship projects must be based on the advancement of the basic knowledge of the industry as a whole. Therefore, it is difficult for us to see phenomena-level biomedical enterprises. In recent years, the following four changes have made people more optimistic about the future of biomedical.

First of all, in the economic environment of cold, the biomedical industry is less affected, and it can even be said that it is against the trend.

“Especially for early biomedical projects, the economy is too hot or too cold,” Dr. Jin Xuecheng said. The cold market is also a natural screening process, and only entrepreneurs who are confident in their own projects will still seek financing at this time. According to him, for investors, this is a good time to find quality projects with relatively little energy. Large companies, when the economy is cold, also value strategic investment, and have a stronger willingness to invest than when the economy is overheated.

Secondly, after long-term development, the bio-pharmaceutical industry has not only accumulated knowledge and experience, but also actively seeks new development directions. Dr. Jin Xuecheng pointed out that in the field of cancer, the five-year survival rate has changed very little in the past 20 years, which means that the past methods are not very effective, and finding new solutions is imperative. With the expansion of the knowledge of biomedical practitioners, the participation of young scientists will also promote industry breakthroughs.

In addition, with the development of information technology and engineering technology for many years, people are looking for new growth points in both software and hardware industries, and biomedicine is an excellent choice. From another perspective, for the practitioners of the biomedical industry, these new ways of thinking and methods from different fields have also greatly enhanced the industry in the past decade. The application of bioinformatics has penetrated into the first-line industries such as hospitals, diagnosis, and drug development. In the future, we can look forward to the golden age of interdisciplinary.

Finally, they are optimistic about the development environment of the biomedical industry. Whether it is from the United States, China or the world, precision medicine is a very hot concept in the last five to ten years, which has driven the public's attention to the biomedical industry. In the past five years, in the US stock market, biosynthetic stocks have also performed very well. Compared with ten years ago, market education has been completed, and the government's promotion and the attention of the big environment have greatly contributed to the development of the biomedical industry.

In summary, the biomedical industry investment is at the right time. According to Dr. He Wei and Dr. Jin Xuecheng, the biomedical industry will continue to rise in the next decade, and the tipping point is likely to appear in the intersection of biomedical and information technology in the next few years.

Laser Distance Sensor

Leading Laser Measure Module Factory in China
The World's First single transmitting single receiving design laser module, which has a big help to reduce producing cost and power consumption of the laser distance sensor.
This Laser distance sensor has high Accuracy up to ±1 mm, working as phase measure, which support RS232/RS422/RS485/Arduino to TTL communication.
This laser distance module is widely used in the Laser Distance Meter industry, also a very good choice for the Industrial applications. Most of measuring tools manufactures is purchasing from us in China.

Product Specifications:

Range Sensor,Laser Distance Module,Distance Sensor,Laser Measure Sensor

Chengdu JRT Meter Technology Co., Ltd , https://www.infrareddistancesensor.com